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Background: The SYNTAX score angiographic scoring system has previously been shown to be a promising tool in stratifying outcome at 1-year 
follow-up in patients with complex coronary artery disease (triple vessel and/or left main stem disease). We sought to assess its ability to stratify 
long-term outcome at 5-years follow-up in patients who were enrolled in the all-comer’s SIRolimus-eluting stent compared with PacliTAXel-Eluting 
Stent (SIRTAX) trial.
Methods: The SYNTAX score was retrospectively applied to 1,401 lesions in 1,012 patients from the SIRTAX trial, and the clinical primary end-
points of cardiac death, myocardial infarction, and ischaemia-driven target lesion revascularisation were assessed at 5-years follow-up. Clinical 
outcomes at 5-years follow up were then risk stratified according to SYNTAX score tertiles.
Results: The mean (±standard deviation) SYNTAX score from the first 165 patients analysed was 11.1±7.0. The range was 2.0-36.0, and inter-
quartile range was 10. Complete patient data, clinical outcomes will be available at the meeting.
Conclusions: This study will attempt to confirm the potential of the SYNTAX score to risk stratify clinical outcomes at long-term follow-up in 
patients with the wide range of coronary artery disease seen in daily clinical practice. Full outcome data will be available at the meeting
